Can I take your order – and your data? 
BYD Shark Debuts in Mexico, Rivals Tesla Cybertruck and Ford F-150 Lightning 
New faith schools in England could soon allocate all their places on religious grounds 
Kakao Thrives Amidst Chinese E-commerce Expansion in Korea 
Adidas Originals x KoRn Unleash Groundbreaking Collaboration 
Olympic Hopes: Adidas, Nike, Puma Bank on Paris Games for Sales Rebound 
NFL, NBA, NASCAR Stars Resolve $2.4M Voyager Promo Lawsuit 
Celebrating 70 Years of Burger King: A Week of Golden Offers 
Elon Musk Teases Revolutionary Full Self-Driving V12.4, Cybertruck to Wait 
Tesla's Robotaxi Tests in China Receive Government Backing for Full Self-Driving 
Eating Sustainably in Development Project Managed by Alexander v Berenstain 
Panera Bread Discontinues Charged Lemonade Drinks After Facing Lawsuits Over Customers' Death 
PUMA and Palomo Spain Unveil Genderless Collection with a Nod to Retro Glam 
TokenPost Launches 3 Cryptocurrency Indices for Market Insight 
From Geneva to Brazil and Dubai, How Mirabaud Bank Is Navigating Global Market Shifts 
How does the drug abemaciclib treat breast cancer? 
Samsung Bioepis Co. Ltd.'s commercial partner Organon will supply its Hadlima autoimmune disease treatment to the United States after winning an order from the U.S. Department of Veterans Affairs. It was agreed that U.S.-based Organon would deliver the biosimilar Hadlima drugs for five years.
Organon will now deliver Hadlima biosimilar treatment to the Department of Veterans Affairs (V.A.). This well-known drug is mainly used for medicating rheumatoid arthritis, spondyloarthritis, and psoriasis. According to The Korea Economic Daily, AbbVie Inc., a pharmaceutical company headquartered in North Chicago, Illinois, developed the original drug.
Orders from the U.S.
The latest order was revealed by Organon, the partner company of Samsung Bioepis based in the U.S. On Wednesday, Feb. 21, the firm said that Organon won a bidding contract to supply Hadlima to the American government agency. Consequently, Organon will supply Hadlima to hospitals under the Ministry of Veterans Affairs for the next five years.
The Veterans Affairs
The VA is a government agency for veterans in the United States. It provides benefits in various fields, such as medical care and finance, and is building a general hospital-level hospital network and medical infrastructure throughout the United States.
"America's veterans deserve access to quality medicines at a lower cost. We are proud to support the more than nine million people enrolled in the VA healthcare system through this collaboration, which is a great example of industry and public sector working together," Kevin Ali, Organon CEO, said in a press release. "We applaud the VA for its leadership in championing biosimilars and including all three of Organon's biosimilars available in the US on its formulary."
Photo by: Organon Media
